Medical/Pharmaceuticals
EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV™ Nanocells to Mount Dual Assault on Cancer Cells
EDV™ Technology Stimulates Both Innate and Adaptive Immune Response and Confers Long-Term Survival Research Paves Way for Treatment of Drug-Resistant, End-Stage Cancers NEW YORK and SYDNEY, March 17, 2020 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its ...
2020-03-17 00:35
1896
China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government
TAIZHOU, China, March 16, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc.
(NASDAQ: SXTC
2020-03-16 21:16
4759
CPHI to Hold Fiscal Year 2019 Earnings Conference Call On Tuesday March 31, 2020 at 8:30 a.m. ET
HAIKOU CITY, China, March 13, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its f...
2020-03-13 20:30
6100
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019
BEIJING, March 12, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its financial results for the fourth quarter and fiscal year of 2019. Fourt...
2020-03-13 05:00
10139
WuXi AppTec Wuhan Site Resumes Operation
SHANGHAI, March 11, 2020 /PRNewswire/ -- WuXi AppTec announced today that the company'sWuhan site has resumed operations, in compliance with local regulations and global COVID-19 health and safety guidelines. Operations at the Wuhan facility, which provides discovery chemistry services, will ramp ...
2020-03-11 20:00
1537
Concord Medical Welcomes RMB700 Million Investment
BEIJING, March 11, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research, education and prevention by operating a network of medically advanced comprehensive cancer hospitals and...
2020-03-11 15:40
5499
CIMC-produced Mobile Cabins Put Into Use in Chinese Hospitals to Help Combat Coronavirus
SHENZHEN, China, March 9, 2020 /PRNewswire/ -- The first mobile CT scan cabin produced by Yangzhou Tailee Special Equipment Co Ltd (A member enterprise of CIMC) has been put into use in a hospital in Huanggang, one of the worst hit cities by the coronavirus outbreak inHubei province, to help with...
2020-03-10 09:30
1520
NDA Filing for Luye Pharma's Antidepressant Drug LY03005 Accepted by the U.S. FDA
SHANGHAI, March. 4, 2020 /PRNewswire/ -- Luye Pharma Group has announced that the U.S. Food and Drug Administration (FDA) has reviewed and accepted the filing of a New Drug Application (NDA) for LY03005, a new chemical drug for the treatment of major depressive disorder. LY03005 is the company's ...
2020-03-04 21:27
1979
China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results
BEIJING, March 3, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its fourth quarter and fiscal year 2019 fi...
2020-03-03 21:30
7652
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
SONGDO, South Korea, March 2, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the agreement, Samsung Biologics will offer a wide range of services from c...
2020-03-03 03:00
1121
Yuyu Pharma announces review of compliance policies and procedures
SEOUL, South Korea, March 2, 2020 /PRNewswire/ -- Yuyu Pharma (COO Robert Wonsang Yu, KRX 000220) announced today a review of its compliance policies and procedures with the support of the law firm, Kim & Chang. The Kim & Chang project team, consisting of 6 lawyers and 1 expert advisor, implement...
2020-03-02 22:00
1089
China Pharmaceutical Holdings Co., Ltd. Launched A New Product
HAIKOU CITY, China, March 2, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that its subsidiary, Hainan ...
2020-03-02 20:00
5911
3SBIO makes investment in MPM's $100M Oncology Innovations Fund and donation to Dana-Farber cancer research
SHANGHAI, March 1, 2020 /PRNewswire/ -- MPM Capital (MPM) and Dana-Farber Cancer Institute have jointly announced onFebruary 26, 2020 the successful closing of the MPM Oncology Innovations Fund (INV) with$100M in capital, and the Dana-Farber Innovations Research Fund (IRF) with more than$26M in p...
2020-03-01 16:30
1099
Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect
SONGDO, South Korea, Feb. 24, 2020 /PRNewswire/ -- Samsung Biologics has been monitoring the COVID-19 situation closely since the initial outbreak in late January and taking proactive measures company-wide to ensure a safe working environment and continuous business operations. The company confi...
2020-02-27 15:49
1376
WuXi Diagnostics' integrated testing solution for COVID-19 epidemiological investigation and diagnosis
SHANGHAI, Feb. 27, 2020 /PRNewswire/ -- WuXi Diagnostics has successfully developed a series of COVID-19 detection products, including2019-nCoV IgM Detection kit (Enzyme-linked Immunoassay, ELISA), 2019-nCoV IgM/IgG Detection Kit (Enzyme-linked Immunoassay, ELISA) and 2019-nCoV Nucleic Acid Detec...
2020-02-27 15:47
1760
New Data Confirms Cardiac Dimensions' Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation
Pooled Analysis of Prospective Studies Presented during Late Breaking Trials Session at CRT 2020 KIRKLAND, Washington, Feb. 25, 2020 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients ...
2020-02-26 00:50
1094
United Imaging's Emergency Radiology Departments Support Mobile Cabin Hospitals, Facilitate 5G Remote Diagnosis
SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- At the center of the epidemic in Wuhan, many sports centers, exhibition halls, and schools have been turned into mobile cabin hospitals (MCHs) to treat tens of thousands of coronavirus patients with mild symptoms. During the epidemic, fast and accurate CT d...
2020-02-25 21:00
1654
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of APG-1387 in Combination with Chemotherapy for the Treatment of Advanced Pancreatic Cancer in China
SUZHOU, China and ROCKVILLE, MD., Feb. 24, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has receive...
2020-02-24 22:00
2208
Emergency Service from 111 Helps Companies Secure Epidemic Supplies to Open for Business
SHANGHAI, Feb. 24, 2020 /PRNewswire/ -- Businesses across China need to secure epidemic supplies such as face masks and disinfectant to re-open factories and offices. Now they will be able to turn to 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthca...
2020-02-24 16:00
4134
WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321
SHANGHAI, Feb. 23, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its strategic partner Immutep, a biotechnology comp...
2020-02-24 08:00
5719
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 326 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 321 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 306 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 276 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
11042
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
9485
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
8967
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
8270
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
7515
